Smiths Medical Acquires Respiratory Device Firm
By HospiMedica staff writers
Posted on 13 Jul 2004
In a move to expand its portfolio of respiratory products, Smiths Medical (London, UK) has acquired DHD Healthcare (Wampsville, NY, USA) for U.S.$55 million.Posted on 13 Jul 2004
DHD's products are used to care for the respiratory needs of patients in a variety of therapeutic and critical care applications. The company had sales of U.S.$21.2 million over the past 12 months. Smiths acquired DHD from Riverside Capital (Cleveland, OH, USA). Smiths Medical is one of the four operating divisions of the Smiths Group plc, which designs and manufactures critical safety systems and products, including medical devices.
"DHD's world class respiratory products will complement and extend the Smiths Medical airway range with high-growth, novel respiratory care devices,” said Lawrence Kinet, managing director of Smiths Medical.
Related Links:
Smiths Medical
DHD Healthcare
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electric Cast Saw
CC4 System
New
Documentation System For Blood Banks
HettInfo II
